Prime Highlights
- Women’s health funding reached a record $1.55 billion in 2025.
- Investment spread across more companies, categories and countries.
Key Facts
- 85 companies raised equity in 2025, the highest annual total recorded.
- Ten funding rounds reached $50 million or more.
Background
Women’s health companies raised a record $1.55 billion in disclosed equity investment in 2025, marking a 41% increase from $1.1 billion in 2024, according to a report by W Group.
The report tracked more than 500 funding announcements and around 164 equity rounds. It found that 85 companies raised equity during 2025, the highest annual total recorded so far. The number of funding rounds worth at least $50 million also doubled to 10 from five in 2024.
Funding also became more spread across the sector. The three biggest deals accounted for 32% of total disclosed capital in 2025, down from 41% a year earlier. Investment in companies outside the top three grew 56% during the year to about $1.05 billion.
The funding reached a wider range of health categories. The 10 deals of $50 million or more covered seven areas, including oncology, fertility, maternal care, menopause, metabolic health, sexual health diagnostics and digital health.
Metabolic and GLP-1 health emerged as a new funding category, led by SheMed’s $50 million Series A. Endometriosis attracted $57 million, while women’s bone health received $8 million.
The investment market also expanded geographically. Germany, Austria, Switzerland, Israel and the UK joined the US as key markets, with several companies focusing on biotechnology and clinical healthcare.
However, major funding gaps remain. Women-focused cardiovascular and autoimmune disease companies received no dedicated equity investment, despite the significant impact of these conditions on women.
W Group also identified a Series A funding bottleneck. While 35 to 40 companies raise pre-seed and seed funding each year, only about 20 to 25 reach Series A. The report said closing this gap will be critical for sustaining growth in 2026.
